跳至主要内容
临床试验/EUCTR2014-004318-27-NO
EUCTR2014-004318-27-NO进行中(未招募)1 期

Intravenous bisphosphonate in stress fracture treatment -A randomised controlled double blinded multicenter trial

Oslo University Hospital0 个研究点目标入组 40 人开始时间: 2016年5月2日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • •-Age 18-70 years
  • •-Stress fractures in the foot. A stress fracture is defined as a fracture occured after repetitive trauma, with characteristic MRI findings (ref) and distinctive pain over the fracture site at weight bearing.
  • •-at least 6 months of pain history
  • •-compliant patient
  • •-non-aided ambulatory patient prior to the injury
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range 32
  • •F.1.3 Elderly (>=65 years) yes
  • •F.1.3.1 Number of subjects for this age range 8

排除标准

  • •-Ongoing use of bisphosphonates, PTH/PTH-analogues or use within 12 months prior to the injury
  • •-Use of bisphophonates for more than 6 months within the last 5 years
  • •-Intolerance to zoledronic acid
  • •-Renal failure (GFR<30)
  • •-S-25(OH)vitD > 25
  • •-pregnancy
  • •-breast feeding
  • •-hypocalcemia
  • •-MRI contraindications

研究者

发起方
Oslo University Hospital

相似试验

Intravenous bisphosphonate in stress fracture... | 临床试验